Percutaneous radiofrequency ablation has seen increased utilization secondary to the rising incidence of renal cell carcinoma. This has been shown to be an effective and durable treatment especially in the elderly comorbid patient. In this article, we describe our technique and factors related to successful outcomes.
You are browsing the legacy CJU website. The journal is now
published by Tech Science Press, and the latest issues, articles and
submission information are available on our new website.